
    
      This is a prospective, non-randomized, non-controlled observational clinical trial. Up to 200
      subjects will be enrolled at up to 6 participating clinical sites. The trial will include
      male and female patients, 18 years or older, requiring replacement for a diseased, damaged,
      or malfunctioning native or prosthetic valve. Patients will be followed and assessed after
      implant for up to 5 years.
    
  